Article By:
Zacks Investment Research
Friday, October 15, 2021 10:42 AM EDT
The company is running a loss so there is no forward PE to lean on. I see 8x book multiple which is a little high. The price to sales multiple is 10.2x, and that too is a bit high.
In this article: HCAT